secwatch.observer — SEC 8-K summary
======================================

Issuer:     WEST PHARMACEUTICAL SERVICES INC (WST)
CIK:        0000105770
Form:       8-K
Filed at:   2025-09-11T23:59:59+00:00
Accession:  0000105770-25-000083
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

General Counsel Kimberly Banks MacKay departing; transition through Dec 31, 2025
--------------------------------------------------------------------------------

- Kimberly Banks MacKay, SVP, General Counsel & Corporate Secretary, is leaving West Pharmaceutical.
- Transition period agreed, ending no later than December 31, 2025.
- MacKay will continue her current duties until departure.
- Company expressed gratitude for her service.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/105770/000010577025000083/0000105770-25-000083-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/105770/000010577025000083/wst-20250911.htm
  HTML page:      https://secwatch.observer/filing/0000105770-25-000083

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer